Pharmaceutical Payments to Authors of Dermatology Guidelines After Publication.
作者信息
Sivesind Torunn E, Szeto Mindy D, Anderson Jarett, Maghfour Jalal, Matheny Maya, Le Quan Nguyen Minh, Kamara Michael, Dellavalle Robert
机构信息
Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Arizona College of Osteopathic Medicine, Glendale, AZ, United States.
出版信息
JMIR Dermatol. 2022 Jun 20;5(2):e37749. doi: 10.2196/37749.
Abstract
摘要
相似文献
1
Pharmaceutical Payments to Authors of Dermatology Guidelines After Publication.皮肤科指南发布后制药公司向指南作者的付款情况。
JMIR Dermatol. 2022 Jun 20;5(2):e37749. doi: 10.2196/37749.
2
Evaluating Industry Payments Among Dermatology Clinical Practice Guidelines Authors.评估皮肤科临床实践指南作者的行业报酬。
JAMA Dermatol. 2017 Dec 1;153(12):1229-1235. doi: 10.1001/jamadermatol.2017.3109.
3
Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.评价日本肿瘤临床实践指南作者的制药公司支付情况和利益冲突披露
JAMA Netw Open. 2019 Apr 5;2(4):e192834. doi: 10.1001/jamanetworkopen.2019.2834.
4
Financial Disclosures Reported by Industry Among Authors of the American Academy of Ophthalmology Clinical Practice Guidelines.行业报告的眼科医师在《美国眼科学会临床实践指南》中的财务披露。
JAMA Ophthalmol. 2023 Apr 1;141(4):378-383. doi: 10.1001/jamaophthalmol.2023.0267.
5
Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan.制药公司向日本皮肤病学临床实践指南作者支付报酬的情况。
PLoS One. 2020 Oct 13;15(10):e0239610. doi: 10.1371/journal.pone.0239610. eCollection 2020.
6
Financial Conflicts of Interest Among Authors of Urology Clinical Practice Guidelines.泌尿外科临床实践指南作者的财务利益冲突。
Eur Urol. 2018 Sep;74(3):348-354. doi: 10.1016/j.eururo.2018.04.023. Epub 2018 May 7.
7
[Financial contributions to guideline group members from industry: An analysis based on the US Open Payments database].[行业对指南组成员的资金贡献：基于美国公开支付数据库的分析]
Z Evid Fortbild Qual Gesundhwes. 2020 Aug;153-154:39-43. doi: 10.1016/j.zefq.2020.05.003. Epub 2020 Jun 15.
8
Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan.日本泌尿科临床实践指南作者与制药公司之间的财务利益冲突。
Int Urogynecol J. 2021 Feb;32(2):443-451. doi: 10.1007/s00192-020-04547-3. Epub 2020 Nov 5.
9
Accuracy of post-publication Financial Conflict of Interest corrections in medical research: A secondary analysis of pharmaceutical company payments to the authors of the CREATE-X trial report in the New England Journal of Medicine.医学研究中已发表的财务利益冲突更正的准确性：对《新英格兰医学杂志》中 CREATE-X 试验报告作者的制药公司支付款项的二次分析。
Bioethics. 2021 Sep;35(7):704-713. doi: 10.1111/bioe.12854. Epub 2021 Jun 16.
10
Financial payments made by pharmaceutical companies to the authors of Japanese hematology clinical practice guidelines between 2016 and 2017.2016 至 2017 年期间，制药公司向日本血液学临床实践指南作者支付的财务报酬。
Health Policy. 2021 Mar;125(3):320-326. doi: 10.1016/j.healthpol.2020.12.005. Epub 2020 Dec 17.
引用本文的文献
1
Industry payments to American Society of Hematology Clinical Practice Guideline authors.制药行业向美国血液学会临床实践指南作者支付的款项。
Blood Adv. 2024 Jul 9;8(13):3549-3552. doi: 10.1182/bloodadvances.2023012527.
本文引用的文献
1
Modernizing clinical practice guidelines for the American Academy of Dermatology.美国皮肤病学会临床实践指南的现代化。
J Am Acad Dermatol. 2020 Jun;82(6):1487-1489. doi: 10.1016/j.jaad.2019.12.075. Epub 2020 Jan 21.
2
Analysis of conflicts of interest in pharmaceutical payments made to Food and Drug Administration physician advisers after dermatologic drug approval.皮肤病药物获批后制药公司向美国食品药品监督管理局医生顾问支付款项的利益冲突分析。
J Am Acad Dermatol. 2019 Dec;81(6):1419-1420. doi: 10.1016/j.jaad.2019.05.059. Epub 2019 May 29.
3
Evaluating Industry Payments Among Dermatology Clinical Practice Guidelines Authors.评估皮肤科临床实践指南作者的行业报酬。
JAMA Dermatol. 2017 Dec 1;153(12):1229-1235. doi: 10.1001/jamadermatol.2017.3109.
4
Conflict of Interest in Practice Guidelines Panels.实践指南小组中的利益冲突。
JAMA. 2017 May 2;317(17):1739-1740. doi: 10.1001/jama.2017.2701.
5
Conflict of interest guidelines for clinical guidelines.临床指南的利益冲突准则。
Med J Aust. 2011 Oct 17;195(8):442-5. doi: 10.5694/mja10.11130.
Zotero 插件